Role of khadirastak kwatha and manjisthadi taila(external application) in treatment of psoriasis

Clinical Evaluation of Khadirastaka Kvatha and Local Application of Manjisthadi Taila in the Management of Psoriasis - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/04/065046

Enrollment

Registered

2024-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: patients will be diagnosed with psoriasis with the help of presence of signs and symptoms like scaling(dalana),itching(kandu),erythema (krusna aruna varna),loss of perspiration (asvedanam),dryness(rukshta),auspitz sign,candle grease sign,koebners phenomenon

Exclusion criteria

Exclusion criteria: 1.Pregnant or lactating females. 2.Patients who have taken medicine of corticosteroid drugs or immune-suppressants or other biological medicines within last 6 months. 3.Known case of diseases like AIDS, STD, TB, heart diseases and other disorders which lead to fetal condition for the patients. 4.Patients having diabetes mellitus. 5.Other concomitant skin disease occurring with allergic reaction of any other disease.

Design outcomes

Primary

Measure	Time frame
To observe and find out changes in signs and symptoms of the psoriasis after the oral administration of khadirastaka kwatha and local application of manjisthadi taila.Timepoint: 2 weeks	—

Secondary

Measure	Time frame
1.To evaluate the changes in PASI index in the patients of psoriasis. 2.To find out the improvement in quality of life through changes in DLQI in the patients of psoriasis. Timepoint: 8 weeks	—

Countries

India

Contacts

Public ContactProf Dr Manish Patel

J.S.Ayurved Mahavidyalay

manishayu97@yahoo.com9979589865

Outcome results